Exercise or conversion by Westby Keith of 13298 shares of IVERIC Bio subject to Rule 16b-3

ISEEDelisted Stock  USD 39.95  0.00  0.00%   
About 56% of IVERIC Bio's investor base is looking to short. The analysis of current outlook of investing in IVERIC Bio suggests that many traders are alarmed regarding IVERIC Bio's prospects. The current market sentiment, together with IVERIC Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use IVERIC Bio stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Iveric Bio Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
IVERIC insider trading alert for exercise of common stock by Westby Keith, SVP Chief Operating Officer, on 6th of March 2023. This event was filed by Iveric Bio Inc with SEC on 2023-03-06. Statement of changes in beneficial ownership - SEC Form 4

IVERIC Bio Fundamental Analysis

We analyze IVERIC Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IVERIC Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IVERIC Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

IVERIC Bio is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

IVERIC Bio Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IVERIC Bio stock to make a market-neutral strategy. Peer analysis of IVERIC Bio could also be used in its relative valuation, which is a method of valuing IVERIC Bio by comparing valuation metrics with similar companies.

Peers

IVERIC Bio Related Equities

APLSApellis Pharmaceuticals   10.88   
0%
100.0%
ROIVRoivant Sciences   6.01   
0%
55.0%
MDGLMadrigal Pharmaceuticals   5.53   
0%
50.0%
AKROAkero Therapeutics   4.90   
0%
45.0%
ETNB89bio   4.53   
0%
41.0%
KRYSKrystal Biotech   4.45   
0%
40.0%
ACLXArcellx   3.69   
0%
33.0%
DAWNDay One   2.85   
0%
26.0%
VKTXViking Therapeutics   1.86   
0%
17.0%
AMLXAmylyx Pharmaceuticals   1.54   
0%
14.0%
STOKStoke Therapeutics   1.42   
0%
13.0%
TERNTerns Pharmaceuticals   1.40   
0%
12.0%
IMVTImmunovant   1.24   
0%
11.0%
PLRXPliant Therapeutics   1.01   
0%
9.0%
BPMCBlueprint Medicines   2.56   
23.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in IVERIC Stock

If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Managers
Screen money managers from public funds and ETFs managed around the world